Brevan Howard Capital Management LP Oric Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 49,095 shares of ORIC stock, worth $642,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,095
Previous 34,725
41.38%
Holding current value
$642,653
Previous $352,000
66.19%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
157Shares Held
105MCall Options Held
35.1KPut Options Held
173K-
Nextech Invest, Ltd. Zurich, V87.16MShares$93.8 Million13.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$88.1 Million6.03% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$86.4 Million11.96% of portfolio
-
Viking Global Investors LP6.57MShares$86 Million0.22% of portfolio
-
Nextech Invest Ag5.29MShares$69.2 Million7.95% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $518M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...